Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Transmucosal Drug Delivery Systems Market 2020 By Manufacturers, Regions, Type, And Application, Forecast To 2026

  • Purchase Options

 

Summary

The global Transmucosal Drug Delivery Systems Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

The Transmucosal Drug Delivery Systems Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Transmucosal Drug Delivery Systems Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • 3M
  • Antares Pharma
  • Aveva Drug Delivery Systems
  • Corium International
  • Acrux Limited
  • ALZA Corporation
  • DURECT Corporation
  • Generex Biotechnology

By the Product Type, the market is primarily segmented into:

  • Oral Drug Delivery
  • Nasal Drug Delivery
  • Rectal Drug Delivery
  • Other
  • Market segment by Application, split into
  • Hospitals
  • Clinics
  • Others

By Applications, the market is segmented into:

  • Hospitals
  • Clinics
  • Others

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Transmucosal Drug Delivery Systems Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Transmucosal Drug Delivery Systems Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Transmucosal Drug Delivery Systems Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Transmucosal Drug Delivery Systems Market

The Transmucosal Drug Delivery Systems Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Transmucosal Drug Delivery Systems Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Transmucosal Drug Delivery Systems Revenue
1.4 Market Analysis by Type
1.4.1 Global Transmucosal Drug Delivery Systems Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral Drug Delivery
1.4.3 Nasal Drug Delivery
1.4.4 Rectal Drug Delivery
1.4.5 Other
1.5 Market by Application
1.5.1 Global Transmucosal Drug Delivery Systems Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends by Regions
2.1 Transmucosal Drug Delivery Systems Market Perspective (2015-2026)
2.2 Transmucosal Drug Delivery Systems Growth Trends by Regions
2.2.1 Transmucosal Drug Delivery Systems Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Transmucosal Drug Delivery Systems Historic Market Share by Regions (2015-2020)
2.2.3 Transmucosal Drug Delivery Systems Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Transmucosal Drug Delivery Systems Market Growth Strategy
2.3.6 Primary Interviews with Key Transmucosal Drug Delivery Systems Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Transmucosal Drug Delivery Systems Players by Market Size
3.1.1 Global Top Transmucosal Drug Delivery Systems Players by Revenue (2015-2020)
3.1.2 Global Transmucosal Drug Delivery Systems Revenue Market Share by Players (2015-2020)
3.1.3 Global Transmucosal Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Transmucosal Drug Delivery Systems Market Concentration Ratio
3.2.1 Global Transmucosal Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Transmucosal Drug Delivery Systems Revenue in 2019
3.3 Transmucosal Drug Delivery Systems Key Players Head office and Area Served
3.4 Key Players Transmucosal Drug Delivery Systems Product Solution and Service
3.5 Date of Enter into Transmucosal Drug Delivery Systems Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Transmucosal Drug Delivery Systems Historic Market Size by Type (2015-2020)
4.2 Global Transmucosal Drug Delivery Systems Forecasted Market Size by Type (2021-2026)

5 Transmucosal Drug Delivery Systems Breakdown Data by Application (2015-2026)
5.1 Global Transmucosal Drug Delivery Systems Market Size by Application (2015-2020)
5.2 Global Transmucosal Drug Delivery Systems Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Transmucosal Drug Delivery Systems Market Size (2015-2020)
6.2 Transmucosal Drug Delivery Systems Key Players in North America (2019-2020)
6.3 North America Transmucosal Drug Delivery Systems Market Size by Type (2015-2020)
6.4 North America Transmucosal Drug Delivery Systems Market Size by Application (2015-2020)

7 Europe
7.1 Europe Transmucosal Drug Delivery Systems Market Size (2015-2020)
7.2 Transmucosal Drug Delivery Systems Key Players in Europe (2019-2020)
7.3 Europe Transmucosal Drug Delivery Systems Market Size by Type (2015-2020)
7.4 Europe Transmucosal Drug Delivery Systems Market Size by Application (2015-2020)

8 China
8.1 China Transmucosal Drug Delivery Systems Market Size (2015-2020)
8.2 Transmucosal Drug Delivery Systems Key Players in China (2019-2020)
8.3 China Transmucosal Drug Delivery Systems Market Size by Type (2015-2020)
8.4 China Transmucosal Drug Delivery Systems Market Size by Application (2015-2020)

9 Japan
9.1 Japan Transmucosal Drug Delivery Systems Market Size (2015-2020)
9.2 Transmucosal Drug Delivery Systems Key Players in Japan (2019-2020)
9.3 Japan Transmucosal Drug Delivery Systems Market Size by Type (2015-2020)
9.4 Japan Transmucosal Drug Delivery Systems Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Transmucosal Drug Delivery Systems Market Size (2015-2020)
10.2 Transmucosal Drug Delivery Systems Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Transmucosal Drug Delivery Systems Market Size by Type (2015-2020)
10.4 Southeast Asia Transmucosal Drug Delivery Systems Market Size by Application (2015-2020)

11 India
11.1 India Transmucosal Drug Delivery Systems Market Size (2015-2020)
11.2 Transmucosal Drug Delivery Systems Key Players in India (2019-2020)
11.3 India Transmucosal Drug Delivery Systems Market Size by Type (2015-2020)
11.4 India Transmucosal Drug Delivery Systems Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Transmucosal Drug Delivery Systems Market Size (2015-2020)
12.2 Transmucosal Drug Delivery Systems Key Players in Central & South America (2019-2020)
12.3 Central & South America Transmucosal Drug Delivery Systems Market Size by Type (2015-2020)
12.4 Central & South America Transmucosal Drug Delivery Systems Market Size by Application (2015-2020)

13Key Players Profiles
13.1 3M
13.1.1 3M Company Details
13.1.2 3M Business Overview and Its Total Revenue
13.1.3 3M Transmucosal Drug Delivery Systems Introduction
13.1.4 3M Revenue in Transmucosal Drug Delivery Systems Business (2015-2020))
13.1.5 3M Recent Development
13.2 Antares Pharma
13.2.1 Antares Pharma Company Details
13.2.2 Antares Pharma Business Overview and Its Total Revenue
13.2.3 Antares Pharma Transmucosal Drug Delivery Systems Introduction
13.2.4 Antares Pharma Revenue in Transmucosal Drug Delivery Systems Business (2015-2020)
13.2.5 Antares Pharma Recent Development
13.3 Aveva Drug Delivery Systems
13.3.1 Aveva Drug Delivery Systems Company Details
13.3.2 Aveva Drug Delivery Systems Business Overview and Its Total Revenue
13.3.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Systems Introduction
13.3.4 Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Systems Business (2015-2020)
13.3.5 Aveva Drug Delivery Systems Recent Development
13.4 Corium International
13.4.1 Corium International Company Details
13.4.2 Corium International Business Overview and Its Total Revenue
13.4.3 Corium International Transmucosal Drug Delivery Systems Introduction
13.4.4 Corium International Revenue in Transmucosal Drug Delivery Systems Business (2015-2020)
13.4.5 Corium International Recent Development
13.5 Acrux Limited
13.5.1 Acrux Limited Company Details
13.5.2 Acrux Limited Business Overview and Its Total Revenue
13.5.3 Acrux Limited Transmucosal Drug Delivery Systems Introduction
13.5.4 Acrux Limited Revenue in Transmucosal Drug Delivery Systems Business (2015-2020)
13.5.5 Acrux Limited Recent Development
13.6 ALZA Corporation
13.6.1 ALZA Corporation Company Details
13.6.2 ALZA Corporation Business Overview and Its Total Revenue
13.6.3 ALZA Corporation Transmucosal Drug Delivery Systems Introduction
13.6.4 ALZA Corporation Revenue in Transmucosal Drug Delivery Systems Business (2015-2020)
13.6.5 ALZA Corporation Recent Development
13.7 DURECT Corporation
13.7.1 DURECT Corporation Company Details
13.7.2 DURECT Corporation Business Overview and Its Total Revenue
13.7.3 DURECT Corporation Transmucosal Drug Delivery Systems Introduction
13.7.4 DURECT Corporation Revenue in Transmucosal Drug Delivery Systems Business (2015-2020)
13.7.5 DURECT Corporation Recent Development
13.8 Generex Biotechnology
13.8.1 Generex Biotechnology Company Details
13.8.2 Generex Biotechnology Business Overview and Its Total Revenue
13.8.3 Generex Biotechnology Transmucosal Drug Delivery Systems Introduction
13.8.4 Generex Biotechnology Revenue in Transmucosal Drug Delivery Systems Business (2015-2020)
13.8.5 Generex Biotechnology Recent Development

14Analyst's Viewpoints/Conclusions

15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Table
List of Tables

Table 1. Transmucosal Drug Delivery Systems Key Market Segments
Table 2. Key Players Covered: Ranking by Transmucosal Drug Delivery Systems Revenue
Table 3. Ranking of Global Top Transmucosal Drug Delivery Systems Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Transmucosal Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral Drug Delivery
Table 6. Key Players of Nasal Drug Delivery
Table 7. Key Players of Rectal Drug Delivery
Table 8. Key Players of Other
Table 9. Global Transmucosal Drug Delivery Systems Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Transmucosal Drug Delivery Systems Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Transmucosal Drug Delivery Systems Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Transmucosal Drug Delivery Systems Market Share by Regions (2015-2020)
Table 13. Global Transmucosal Drug Delivery Systems Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Transmucosal Drug Delivery Systems Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Transmucosal Drug Delivery Systems Market Growth Strategy
Table 19. Main Points Interviewed from Key Transmucosal Drug Delivery Systems Players
Table 20. Global Transmucosal Drug Delivery Systems Revenue by Players (2015-2020) (Million US$)
Table 21. Global Transmucosal Drug Delivery Systems Market Share by Players (2015-2020)
Table 22. Global Top Transmucosal Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transmucosal Drug Delivery Systems as of 2019)
Table 23. Global Transmucosal Drug Delivery Systems by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Transmucosal Drug Delivery Systems Product Solution and Service
Table 26. Date of Enter into Transmucosal Drug Delivery Systems Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Transmucosal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 29. Global Transmucosal Drug Delivery Systems Market Size Share by Type (2015-2020)
Table 30. Global Transmucosal Drug Delivery Systems Revenue Market Share by Type (2021-2026)
Table 31. Global Transmucosal Drug Delivery Systems Market Size Share by Application (2015-2020)
Table 32. Global Transmucosal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 33. Global Transmucosal Drug Delivery Systems Market Size Share by Application (2021-2026)
Table 34. North America Key Players Transmucosal Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Transmucosal Drug Delivery Systems Market Share (2019-2020)
Table 36. North America Transmucosal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 37. North America Transmucosal Drug Delivery Systems Market Share by Type (2015-2020)
Table 38. North America Transmucosal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 39. North America Transmucosal Drug Delivery Systems Market Share by Application (2015-2020)
Table 40. Europe Key Players Transmucosal Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Transmucosal Drug Delivery Systems Market Share (2019-2020)
Table 42. Europe Transmucosal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Transmucosal Drug Delivery Systems Market Share by Type (2015-2020)
Table 44. Europe Transmucosal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Transmucosal Drug Delivery Systems Market Share by Application (2015-2020)
Table 46. China Key Players Transmucosal Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 47. China Key Players Transmucosal Drug Delivery Systems Market Share (2019-2020)
Table 48. China Transmucosal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 49. China Transmucosal Drug Delivery Systems Market Share by Type (2015-2020)
Table 50. China Transmucosal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 51. China Transmucosal Drug Delivery Systems Market Share by Application (2015-2020)
Table 52. Japan Key Players Transmucosal Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Transmucosal Drug Delivery Systems Market Share (2019-2020)
Table 54. Japan Transmucosal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Transmucosal Drug Delivery Systems Market Share by Type (2015-2020)
Table 56. Japan Transmucosal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Transmucosal Drug Delivery Systems Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Transmucosal Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Transmucosal Drug Delivery Systems Market Share (2019-2020)
Table 60. Southeast Asia Transmucosal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Transmucosal Drug Delivery Systems Market Share by Type (2015-2020)
Table 62. Southeast Asia Transmucosal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Transmucosal Drug Delivery Systems Market Share by Application (2015-2020)
Table 64. India Key Players Transmucosal Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 65. India Key Players Transmucosal Drug Delivery Systems Market Share (2019-2020)
Table 66. India Transmucosal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 67. India Transmucosal Drug Delivery Systems Market Share by Type (2015-2020)
Table 68. India Transmucosal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 69. India Transmucosal Drug Delivery Systems Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Transmucosal Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Transmucosal Drug Delivery Systems Market Share (2019-2020)
Table 72. Central & South America Transmucosal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Transmucosal Drug Delivery Systems Market Share by Type (2015-2020)
Table 74. Central & South America Transmucosal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Transmucosal Drug Delivery Systems Market Share by Application (2015-2020)
Table 76. 3M Company Details
Table 77. 3M Business Overview
Table 78. 3M Product
Table 79. 3M Revenue in Transmucosal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 80. 3M Recent Development
Table 81. Antares Pharma Company Details
Table 82. Antares Pharma Business Overview
Table 83. Antares Pharma Product
Table 84. Antares Pharma Revenue in Transmucosal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 85. Antares Pharma Recent Development
Table 86. Aveva Drug Delivery Systems Company Details
Table 87. Aveva Drug Delivery Systems Business Overview
Table 88. Aveva Drug Delivery Systems Product
Table 89. Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 90. Aveva Drug Delivery Systems Recent Development
Table 91. Corium International Company Details
Table 92. Corium International Business Overview
Table 93. Corium International Product
Table 94. Corium International Revenue in Transmucosal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 95. Corium International Recent Development
Table 96. Acrux Limited Company Details
Table 97. Acrux Limited Business Overview
Table 98. Acrux Limited Product
Table 99. Acrux Limited Revenue in Transmucosal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 100. Acrux Limited Recent Development
Table 101. ALZA Corporation Company Details
Table 102. ALZA Corporation Business Overview
Table 103. ALZA Corporation Product
Table 104. ALZA Corporation Revenue in Transmucosal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 105. ALZA Corporation Recent Development
Table 106. DURECT Corporation Company Details
Table 107. DURECT Corporation Business Overview
Table 108. DURECT Corporation Product
Table 109. DURECT Corporation Revenue in Transmucosal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 110. DURECT Corporation Recent Development
Table 111. Generex Biotechnology Business Overview
Table 112. Generex Biotechnology Product
Table 113. Generex Biotechnology Company Details
Table 114. Generex Biotechnology Revenue in Transmucosal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 115. Generex Biotechnology Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transmucosal Drug Delivery Systems Market Share by Type: 2020 VS 2026
Figure 2. Oral Drug Delivery Features
Figure 3. Nasal Drug Delivery Features
Figure 4. Rectal Drug Delivery Features
Figure 5. Other Features
Figure 6. Global Transmucosal Drug Delivery Systems Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Transmucosal Drug Delivery Systems Report Years Considered
Figure 11. Global Transmucosal Drug Delivery Systems Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Transmucosal Drug Delivery Systems Market Share by Regions: 2020 VS 2026
Figure 13. Global Transmucosal Drug Delivery Systems Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Transmucosal Drug Delivery Systems Market Share by Players in 2019
Figure 16. Global Top Transmucosal Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transmucosal Drug Delivery Systems as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Transmucosal Drug Delivery Systems Revenue in 2019
Figure 18. North America Transmucosal Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Transmucosal Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Transmucosal Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Transmucosal Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Transmucosal Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Transmucosal Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Transmucosal Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. 3M Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. 3M Revenue Growth Rate in Transmucosal Drug Delivery Systems Business (2015-2020)
Figure 27. Antares Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Antares Pharma Revenue Growth Rate in Transmucosal Drug Delivery Systems Business (2015-2020)
Figure 29. Aveva Drug Delivery Systems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Aveva Drug Delivery Systems Revenue Growth Rate in Transmucosal Drug Delivery Systems Business (2015-2020)
Figure 31. Corium International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Corium International Revenue Growth Rate in Transmucosal Drug Delivery Systems Business (2015-2020)
Figure 33. Acrux Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Acrux Limited Revenue Growth Rate in Transmucosal Drug Delivery Systems Business (2015-2020)
Figure 35. ALZA Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. ALZA Corporation Revenue Growth Rate in Transmucosal Drug Delivery Systems Business (2015-2020)
Figure 37. DURECT Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. DURECT Corporation Revenue Growth Rate in Transmucosal Drug Delivery Systems Business (2015-2020)
Figure 39. Generex Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Generex Biotechnology Revenue Growth Rate in Transmucosal Drug Delivery Systems Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us